Cardiovascular implants are used to treat heart diseases. Implantable devices are sophisticated modern devices that provide patients with several benefits. Cardiovascular implants are meant to remain inside a patient’s body for the proper functioning of heart and blood vessels. Cardiovascular implants are of two primary types: one that remains inside a patient after s/he goes home and the other is used only during surgery or over the course of the patient’s hospital stay. Cardiac implantable device design has witnessed rapid changes in terms of size and technical features in the past few years.
Based on device type, the global cardiovascular implant devices market can be classified into cardiac rhythm management devices, interventional cardiac devices, and prosthetic devices. The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals.
Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
In terms of region, the global cardiovascular implants market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is expected to account for a significant share of the global market during the forecast period, due to rise in prevalence of heart disorders because of unhealthy lifestyle. Moreover, according to American Heart Association report (2015), about 85.6 million people suffer from cardiovascular diseases in U.S. Increase in geriatric population and availability of reimbursement for implantable devices are likely to propel the market in Europe from 2018 to 2026. Additionally, rise in prevalence of cardiovascular diseases boost the growth of the market in the region. According to European Cardiovascular Disease Statistics (2017), cardiovascular diseases accounted for 455 deaths in Europe in 2017. Surge in prevalence of cardiac disorders and increase in adoption of advanced diagnostic tools in the health care system are likely to augment the market in Asia Pacific during the forecast period. According to the European Heart Journal (2016), prevalence of cardiovascular diseases is increasing in China. Rise in prevalence of cardiovascular diseases, availability of modern diagnostic tests and procedures, and established health care infrastructure are likely to boost the growth of the cardiovascular implants market in Middle East & Africa during the forecast period.
Key players operating in the global cardiovascular implants market are Edwards Life sciences Corporation, Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Terumo Corporation, BIOTRONIK, and LEPU MEDICAL, among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.